Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | TSHR | P16473 | 6/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10560031 | 0.96 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| Hydrochloric Acid SCHEMBL29742149 | 0.96 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| SCHEMBL11851387 | 0.96 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| Ammonia Solution, Strong SCHEMBL10353912 | 0.96 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| SCHEMBL7027927 | 0.96 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| SCHEMBL2809108 | 0.96 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| Hydrochloric Acid SCHEMBL29391525 | 0.93 | ALDH1A1 (0.35) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| Ethyne SCHEMBL2390599 | 0.93 | ALDH1A1 (0.35) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| Ethylene SCHEMBL6059829 | 0.93 | ALDH1A1 (0.35) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| Ammonia Solution, Strong SCHEMBL31046202 | 0.84 | BBOX1 (0.32) | ALDH1A1BBOX1EHMT2EHMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 542 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114057558-B | Synthesis method, catalytic system and application of 3, 5-trimethylhexanal | 上海簇睿低碳能源技术有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-110833835-B | Preparation method of carbon-coated metal particle anchored nano catalytic material | 广西大学 | 2023-06-09 | — | — | CN | claimed |
| EP-4103572-A1 | PREPARATION OF A P2X3 ANTAGONIST | Bellus Health Cough Inc. (CA) | 2022-12-21 | — | — | EP | claimed |
| EP-3797107-B1 | HETEROCONDENSED PYRIDONE COMPOUNDS AND THEIR USE AS IDH INHIBITORS | NERVIANO MEDICAL SCIENCES SRL (IT) | 2022-08-10 | — | — | EP | claimed |
| CN-114100541-A | Method for synthesizing isononanal by microchannel reaction device | 上海簇睿低碳能源技术有限公司 | 2022-03-01 | — | — | CN | claimed |
| CN-114057558-A | Synthetic method, catalytic system and application of 3,5, 5-trimethylhexanal | 上海簇睿低碳能源技术有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-107073461-B | Catalyst composition for hydroformylation and hydroformylation process using the same | LG化学株式会社 | 2021-08-27 | — | — | CN | claimed |
| US-20210206759-A1 | HETEROCONDENSED PYRIDONES COMPOUNDS AND THEIR USE AS IDH INHIBITORS | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2021-07-08 | — | — | US | claimed |
| EP-3797107-A1 | HETEROCONDENSED PYRIDONES COMPOUNDS AND THEIR USE AS IDH INHIBITORS | Nerviano Medical Sciences S.r.l. (IT) | 2021-03-31 | — | — | EP | claimed |
| CN-108788125-B | Copper-iridium nanowire and synthetic method thereof | 淮海工学院 | 2020-03-27 | — | — | CN | claimed |
| EP-0424248-B1 | 20,21-Dinoreburnamine derivatives, substituted in position 15, process for their preparation and novel intermediates so obtained, their use as medicines and compositions containing them | ROUSSEL UCLAF (FR) | 1996-01-10 | — | — | EP | claimed |
| WO-1994024113-A1 | METHOD OF PREPARATION OF 6-FLUORO-2-HALOGEN QUINOLINE | RHONE-POULENC RORER S.A. (FR) | 1994-10-27 | — | — | WO | claimed |
| EP-0564723-A1 | An improved process for the synthesis of D(+) Biotin | Council of Scientific and Industrial Research (IN) | 1993-10-13 | — | — | EP | claimed |
| EP-0424248-A2 | 20,21-Dinoreburnamine derivatives, substituted in position 15, process for their preparation and novel intermediates so obtained, their use as medicines and compositions containing them | ROUSSEL UCLAF (FR) | 1991-04-24 | — | — | EP | claimed |
| EP-0190817-B1 | DOPAMINE-BETA-HYDROXYLASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1990-09-05 | — | — | EP | claimed |
| US-4751307-A | Wittig-reaction processes | MALLINCKRODT, INC. (US) | 1988-06-14 | — | — | US | claimed |
| EP-0190817-A1 | Dopamine-beta-hydroxylase inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1986-08-13 | — | — | EP | claimed |
| EP-0093419-B1 | PROCESS FOR PREPARING CHLORO-DIPHENYL PHOSPHANE | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-08-07 | — | — | EP | claimed |
| EP-0006123-B1 | A PTERIDINE DERIVATIVE AND A PROCESS FOR THE PREPARATION OF 10-DEAZAAMINOPTERIN AND ITS DERIVATIVES FROM THE PTERIDINE DERIVATIVE | Southern Research Institute (US) | 1985-01-16 | — | — | EP | claimed |
| US-4411985-A | TRIARYLPHOSPHINES OR TRIARYLPHOSPHORANES STABILIZERS | EASTMAN KODAK COMPANY (US) | 1983-10-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210206759-A1 | HETEROCONDENSED PYRIDONES COMPOUNDS AND THEIR USE AS IDH INHIBITORS | IDH1, IDH2, IDH3A | ALDH1A1 305/4885TSHR 4561/4885TDP1 646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.